← feed

Is NCT02308761 results overdue?

Yes — results are overdue. Primary completion was 2017-08-09; the FDAAA-801 reporting deadline (2018-08-09) passed 2873 days ago and no results are posted on ClinicalTrials.gov.

A Study of RO6870810/TEN-010 in Participants With Acute Myeloid Leukemia and Myelodysplastic Syndrome

NCT IDNCT02308761 ↗
SponsorHoffmann-La Roche (INDUSTRY)
PhasePHASE1
StatusCOMPLETED
Primary completion2017-08-09 (ACTUAL)
Reporting deadline2018-08-09 (completion + 365d)
Days overdue2873
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 7040d8eb4ef9f4d1… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT02308761. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →